Results 271 to 280 of about 98,296 (378)

JAK Inhibitors for Treatment of SAPHO Syndrome: A Systematic Review of 72 Cases

ACR Open Rheumatology, Volume 7, Issue 10, October 2025.
Objective Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome usually involves bones, joints, and skin. Due to a lack of known pathogenesis and clinical trials, there is no standard treatment of SAPHO syndrome. Because none of the current treatments have a high efficacy and the risk of relapse is high, new treatment options for ...
Patrick Fazeli, Saeed Bahramian, Kimia Farahmand, Hamed Ghoshouni, Yalda Farahmand, Amirali Soheili, Leyla Bagheri, Huria Memari, Aydin Feyzi, Seyed Mohammad Vahabi   +9 more
wiley   +1 more source

Pitfalls in the Missed Diagnosis of Atypical Femoral Fracture Presenting as Prodromal Pain that Mimics Degenerative Disease: A Multicenter Study - Secondary Publication of the Japanese Version. [PDF]

J Bone Metab
Fujiwara T, Ohno I, Matsumura N, Oura K, Nakahori Y, Nishii T.   +5 more
europepmc   +1 more source

Medication-Related Osteonecrosis of the Jaws in Patients on Antiresorptive Medication With Dental Implants. A Scoping Review. [PDF]

Clin Oral Implants Res
ABSTRACT Objectives Patients receiving antiresorptive medication (AR) for osteoporosis or cancer are at risk of medication‐related osteonecrosis of the jaws (MRONJ), especially after surgical procedures. Dental implant (DI) placement in high‐dose AR (HDAR) patients is widely discouraged, and thorough counseling is recommended for low‐dose AR (LDAR ...
Andersen SWM, Hindocha NV, Poulsen I, Schliephake H, Jensen SS.   +4 more
europepmc   +2 more sources

Bisphosphonate use and atypical fractures of the femoral shaft.

New England Journal of Medicine, 2011
J. Schilcher, K. Michaëlsson, P. Aspenberg   +2 more
semanticscholar   +1 more source

Gasotransmitters in Modern Medicine: Promises and Challenges in the Use of Porous Crystalline Carriers

Advanced Healthcare Materials, Volume 14, Issue 26, October 7, 2025.
This perspective provides an overview of the growing interest in utilizing various gasotransmitters—small gaseous signaling molecules namely nitric oxide (NO), carbon monoxide (CO), and hydrogen sulfide (H2S)—for several therapeutic applications, with emphasis on the potential use of porous materials as carriers to provide safe and controlled local ...
Rosana V. Pinto, Moisés L. Pinto, Christian Serre   +2 more
wiley   +1 more source

Bridged Mesoporous Oxo-Phosphonates: A General Strategy Toward Functional, Hybrid Materials. [PDF]

Molecules
Gioan E, Su Z, Wang Y, Rodriguez J, Bouchmella K, Alauzun JG.   +5 more
europepmc   +1 more source

Healing Delayed But Generally Reliable After Bisphosphonate-associated Complete Femur Fractures Treated with IM Nails

Clinical Orthopaedics and Related Research, 2014
K. Egol, J. H. Park, Z. Rosenberg, Valerie Peck, N. Tejwani   +4 more
semanticscholar   +1 more source

Biocompatible Mesoporous Materials for Bone Therapy

Advanced Science, Volume 12, Issue 39, October 20, 2025.
Biocompatible mesoporous materials (BMMs), characterized by high specific surface area, tunable pore size, different shapes and structures, and multidimensional functionalized modifications, have revolutionary applications in treating bone‐related diseases.
Biao Yu, Yan Wu, Yang Hong, Peng Wang, Xiaowen Liu, Yonghui Deng, Jiacan Su   +6 more
wiley   +1 more source

Pathophysiology of Femoral Fractures in Hypophosphatasia. [PDF]

Curr Osteoporos Rep
Tabegna FGA, Garton M, D'Amore S, Skingle L, Dillon S, Duer MJ, Clunie GPR, Poole KES.   +7 more
europepmc   +1 more source

The physiology of survival: Space

Experimental Physiology, EarlyView.
Damian M. Bailey, Angelique van Ombergen
wiley   +1 more source